Subject:

Eye on the Market, November 28, 2011

From:
"Mason, Christopher W" christopher.w.mason@jpmorgan.com
To:
"Mason, Christopher W" christopher.w.mason@jpmorgan.com
Date:
2011-11-28 17:51
Attachments:
11-28-11 - EOTM - Deoxyribonucleic Acrimony.pdf

Eye on the Market: November 28, 2011

Why is it taking so long for Europe to take decisive action and rescue its monetary union?  Wednesday Conf Call

 

Michael Cembalest

Chief Investment Officer

 

The material contained herein is intended as a general market commentary. Opinions expressed herein are those of Michael Cembalest and may differ from those of other J.P. Morgan employees and affiliates.  This information in no way constitutes J.P. Morgan research and should not be treated as such. Further, the views expressed herein may differ from that contained in J.P. Morgan research reports.  The above summary/prices/quotes/statistics have been obtained from sources deemed to be reliable, but we do not guarantee their accuracy or completeness, any yield referenced is indicative and subject to change. Past performance is not a guarantee of future results. References to the performance or character of our portfolios generally refer to our Balanced Model Portfolios constructed by J.P. Morgan.  It is a proxy for client performance and may not represent actual transactions or investments in client accounts. The model portfolio can be implemented across brokerage or managed accounts depending on the unique objectives of each client and is serviced through distinct legal entities licensed for specific activities.  Bank, trust and investment management services are provided by J.P. Morgan Chase Bank, N.A, and its affiliates.  Securities are offered through J.P. Morgan Securities LLC (JPMS), Member NYSE, FINRA and SIPC and Chase Investment Services Corp., (CISC) member FINRA and SIPC. Securities products purchased or sold through JPMS or CISC are not insured by the Federal Deposit Insurance Corporation ("FDIC"); are not deposits or other obligations of its bank or thrift affiliates and are not guaranteed by its bank or thrift affiliates; and are subject to investment risks, including possible loss of the principal invested. Not all investment ideas referenced are suitable for all investors. Speak with your J.P. Morgan Representative concerning your personal situation.  This material is not intended as an offer or solicitation for the purchase or sale of any financial instrument. Private Investments may engage in leveraging and other speculative practices that may increase the risk of investment loss, can be highly illiquid, are not required to provide periodic pricing or valuations to investors and may involve complex tax structures and delays in distributing important tax information. Typically such investment ideas can only be offered to suitable investors through a confidential offering memorandum which fully describes all terms, conditions, and risks.

  

IRS Circular 230 Disclosure: JPMorgan Chase & Co. and its affiliates do not provide tax advice.  Accordingly, any discussion of U.S. tax matters contained herein (including any attachments) is not intended or written to be used, and cannot be used, in connection with the promotion, marketing or recommendation by anyone unaffiliated with JPMorgan Chase & Co. of any of the matters addressed herein or for the purpose of avoiding U.S. tax-related penalties.  Note that J.P. Morgan is not a licensed insurance provider.      © 2011 JPMorgan Chase & Co; All rights reserved

 

This email is confidential and subject to important disclaimers and conditions including on offers for the purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal privilege, and legal entity disclaimers, available at http://www.jpmorgan.com/pages/disclosures/email.

Date/Time is diplayed as UTC -03:00

<< Back to home page